Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436

Watchlist Manager
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Logo
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Watchlist
Price: 171.55 CNY 0.74% Market Closed
Market Cap: 103.5B CNY

Zhangzhou Pientzehuang Pharmaceutical Co Ltd's latest stock split occurred on May 24, 2016

The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.

Before the split, Zhangzhou Pientzehuang Pharmaceutical Co Ltd traded at 58.38 per share. Afterward, the share price was about 38.0434.

The adjusted shares began trading on May 24, 2016. This was Zhangzhou Pientzehuang Pharmaceutical Co Ltd's 3rd stock split, following the previous one in Jun 4, 2015.

Last Splits:
May 24, 2016
3-for-2
Jun 4, 2015
5-for-2
Jul 1, 2013
905-for-819
Pre-Split Price
37.6336 58.38
Post-Split Price
38.0434
Before
After
Last Splits:
May 24, 2016
3-for-2
Jun 4, 2015
5-for-2
Jul 1, 2013
905-for-819

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Stock Splits History

Zhangzhou Pientzehuang Pharmaceutical Co Ltd Stock Splits Timeline
May 24, 2016
May 24, 2016
Split 3-for-2
x1.5
Pre-Split Price
37.6336 58.38
Post-Split Price
38.0434
Before
After
Jun 4, 2015
Jun 4, 2015
Split 5-for-2
x2.5
Pre-Split Price
57.4083 224.8901
Post-Split Price
63.5349
Before
After
Jul 1, 2013
Jul 1, 2013
Split 905-for-819
x1.1050061050061
Pre-Split Price
31.1487 136.82
Post-Split Price
31.6422
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Jan 20, 2026
Linius Technologies Ltd
OTC:LNNTF
1-for-100
/100
0.0001 0.0001 USD N/A
Jan 20, 2026
Lotus Resources Ltd
OTC:LTSRF
1-for-11
/11
0.14 0.14 USD N/A
Jan 15, 2026
Amcor PLC
NYSE:AMCR
1-for-5
/5
8.46 8.46 USD N/A
Jan 8, 2026
Sumitomo Realty & Development Co Ltd
OTC:SURYY
2-for-1
x2
25.635 25.635 USD N/A
Jan 6, 2026
Itochu Corp
F:IOC0
10-for-1
x10
106 106 EUR N/A
Load More

Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Glance View

Market Cap
103.4B CNY
Industry
Pharmaceuticals

Zhangzhou Pientzehuang Pharmaceutical Co. Ltd., nestled in the heart of Fujian Province, China, is a firm steeped in history and tradition, yet thriving in today’s modern pharmaceutical landscape. The company is best known for its signature product, Pientzehuang Pills, a centuries-old traditional Chinese medicine believed to offer hepatoprotective and detoxifying properties. Rooted in ancient formulations, Pientzehuang Pills are celebrated for their efficacy in addressing liver ailments and enhancing overall vitality. This has secured their place as a staple in Chinese households, maintaining cultural resonance while appealing to a broader audience through the global rise in demand for alternative medicine. The firm operates with a delicate balance, integrating traditional Chinese medicine practices with increasingly sophisticated production technologies to ensure quality consistency and scalability. Zhangzhou Pientzehuang leverages its brand heritage and expertise in traditional herbal remedies to drive revenue. The company has adeptly positioned itself within both domestic and international markets, capitalizing on the growing interest in holistic health approaches. By focusing on research and development, the company continues to innovate, expanding its product line to include health supplements and preventive solutions that cater to modern health challenges. Its strategic distribution channels, including hospitals, pharmacies, and online platforms, enable broad market penetration, ensuring robust sales growth. This dual strategy of preserving the traditional while embracing the modern allows the company to keep its legacy relevant in a competitive pharmaceutical industry, thereby securing its stronghold in the market and ensuring sustained financial performance.

Intrinsic Value
121.4 CNY
Overvaluation 29%
Intrinsic Value
Price
Back to Top